New NeoChord CEO Todd Berg. [Image from Metavention] NeoChord announced that it appointed Todd Berg as its new CEO to oversee its programs for mitral valve repair. Minneapolis-based NeoChord ...

ST. LOUIS PARK, Minn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company, is leading the advancement of beating heart mitral valve repair in patients ...

ST. LOUIS PARK, Minn., Oct. 04, 2021 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients ...

NeoChord Inc. in Minnetonka, Minn., has raised at least $2.8 million to help it continue to develop a novel way of enabling surgeons to repair bad mitral valves in patients' hearts.

EDEN PRAIRIE, Minn., Jan. 3, 2013—NeoChord, a medical device company focused on minimally invasive mitral valve repair, announced today that it has received CE-marking for its technology that allows ...

1 Cardiac Surgery Unit, Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy 2 Cardiac Surgery Unit, Department of Cardiac, Thoracic and ...

Transapical Neochord mitral valve repair has been proven to be a technically safe procedure to correct primary mitral regurgitation (MR). Recurrent MR due to ruptured artificial chords is rare. Here, ...

The Minnesota-based company has developed the NeoChord DS1000, a disposable device that replaces damaged chordae by delivering artifical chordae tendinae – neochords – in a beating heart using ...